Fact CheckerSign in

NCT05866575Recruiting

Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation

Prediction of the Therapeutic Response in Depression Based on an Early Neuro-computational Modeling Assessment of Motivation

Source: ClinicalTrials.gov · Last updated 10 Jul 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aims to better understand the mechanisms of action of antidepressants, but also the neural correlates of motivation deficits. One hundred patients with a moderate to severe major depressive episode will be enrolled in this prospective multicenter study. The objective will be to predict the therapeutic response to two first-line antidepressants on the basis of an early neurocomputational assessment of motivation. Antidepressant treatment will be administered as monotherapy after randomization between two drugs: escitalopram and vortioxetine. Patients will undergo six visits and follow-up for one year. The investigators will combine computer modeling and functional MRI to identify motivational deficits and elucidate their brain correlates before initiation, after 7 days and after 6 months of treatment. 36 healthy volunteers will also be included to allow comparison with patients with depression. They will not receive any treatment.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
136 (estimated)
First submitted
15 Nov 2022
Start date
12 Sept 2023
Primary completion date
12 Oct 2026
Lead sponsor
Centre Hospitalier St Anne
Diseases
Depression
NCT number
NCT05866575

What you commit to

  • Study type: Interventional
  • Planned participants: 136
  • From 12 Sept 2023 to the primary completion date, 12 Oct 2026
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Subjects with a trial of escitalopram and/or vortioxetine for the current episode, or with contra-indication to one of these two drugs
  • Contraindications to MRI scanning: pregnancy, claustrophobia, metallic implants
  • Contraindications to MRI scanning: pregnancy, claustrophobia, metallic implants

Other illness

  • Subjects with a diagnostic of persistent depressive disorder, bipolar disorder or schizophrenia, neurodeveloppemental disorder, unremitted substance abuse disorder other than tobacco, personality disorder severe enough to compromise the follow-up (based on investigator's appreciation).
  • Subject with a history of neurological disorder: parkinson's disease, dementia
  • Subjects with a diagnostic of persistent depressive disorder, bipolar disorder or schizophrenia, neurodeveloppemental disorder, unremitted substance abuse disorder other than tobacco, personality disorder severe enough to compromise the follow-up (based on investigator's appreciation).
  • Subject with a history of neurological disorder: parkinson's disease, dementia

Other

  • Treatment-resistant depression (defined as insufficient response despite at least 2 trials of antidepressant prescribed at adequate dose and duration)
  • Pregnant or breastfeeding women
  • involuntary hospitalisation and legal protection measures
    • Healthy volunteers
  • Pregnant or breastfeeding women

Who the study is looking for

  • Meeting DSM-5 criteria for major depressive disorder (single or recurrent episodes)
  • With a MADRS score \>= 24
  • For which a new line of treatment is needed
  • No previous line of antidepressant for this episode or wash-out long-enough to avoid carry-over effects
  • Valid health care insurance
  • \- Valid health care insurance

Criteria the registry did not label

  • Patients with major depressive disorder

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Groupe hospitalo-universitaire de Grenoble Alpes
Coordinator of this site? Confirm its status
La TroncheFranceNot yet recruiting
Centre Hospitalier Universitaire de Lille
Coordinator of this site? Confirm its status
LilleFranceNot yet recruiting
Groupe hospitalo-universitaire Assistance Publique, hôpital Pitié Salpêtrière - Hôpitaux de Paris Sorbonne Université
Coordinator of this site? Confirm its status
ParisFranceNot yet recruiting
- Groupe hospitalo-universitaire Paris Psychiatrie et Neurosciences
Coordinator of this site? Confirm its status
ParisFranceRecruiting
Centre Hospitalier Universitaire de Saint Etienne
Coordinator of this site? Confirm its status
Saint-Priest-en-JarezFranceNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.